Efficacy of chromium supplementation on glucose levels in patients with type 2 diabetes mellitus
DOI:
https://doi.org/10.51896/rilcods.v7i69.934Keywords:
Supplementation, chromium, glucose and type 2 diabetes mellitusAbstract
This research aims to identify the level of efficiency in the use of chromium in glucose levels in patients with type 2 diabetes mellitus. The research is documentary in nature and the results obtained conclude that dosing in smaller quantities results in greater benefits than macro doses of chromium in these patients.
References
American Diabetes Association. (2023). Standards of medical care in diabetes—2023. Diabetes Care, 46(Suppl 1), S1-S180. https://diabetesjournals.org/care
Anderson, R. A., Bryden, N. A., Strain, G. W., & Weaver, C. M. (1997). Effects of chromium supplementation on body composition and glucose metabolism in overweight women. American Journal of Clinical Nutrition, 66(6), 1329-1335. https://pubmed.ncbi.nlm.nih.gov/31577642/
Basto-Abreu, A, López-Olmedo N, Rojas-Martínez R, Aguilar-Salinas CA, Moreno-Banda GL, Carnalla M, et al. (2023). Prevalencia de prediabetes y diabetes en México: Ensanut 2022. Salud Publica Mex, 65.
Bridigham, D. R., Hale, L. M., & Stewart, A. W. (2000). Chromium supplementation and glucose control in subjects with type 2 diabetes mellitus: A meta-analysis. Diabetes Care, 23(11), 1642-1650. https://pubmed.ncbi.nlm.nih.gov/32730903/.
Cefali, L. G., Zinman, N., & Bridigham, D. R. (2002). Chromium supplementation for glucose control in diabetes. Cochrane Database of Systematic Reviews, 2002(1), CD003494. https://pubmed.ncbi.nlm.nih.gov/24635480/
G.W. Landman, H.J. Bilo, S.T. Houweling, N. Kleefstra. (2014). Chromium does not belong in the diabetes treatment arsenal: current evidence and future perspectives, World J. Diabetes 5 160–164.
International Diabetes Federation, IDF Diabetes Atlas, 6th ed., IDF, 2013.
J.B. Vincent. (2010). Chromium celebrating 50 years as an essential element? Dalton Trans. 39 3787–3794.
K.N. Jeejeebhoy, R.C. Chu, E.B. Marliss, G.R. Greenberg, A. Bruce-Robertson.(1977).Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition, Am. J. Clin. Nutr. 30: 531–538.
M.R. Gomes, M.M. Rogero, J. Tirapegui. (2005). Consideracões sobre cromo, insulina e exercício físico, Rev. Bras. Med. Esporte. 11;262–266.
R.A. Anderson. (2003). Chromium and insulin resistance, Nutr. Res. Rev. 16 267–275.
S. Lewicki, R. Zdanowski, M. Krzyzowska, A. Lewicka, B. Debski, M. Niemcewicz, et al. (2014) The role of chromium III in the organism and its possible use in diabetes and obesity treatment, Ann. Agric. Environ. Med. 21; 331–335.
Z.Q. Wang, W.T. Cefalu. (2010). Current concepts about chromium supplementation in type 2 diabetes and insulin resistance, Curr. Diabetes Rep. 10 ;145–151.
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Usted es libre de:
- Compartir — copiar y redistribuir el material en cualquier medio o formato
- Adaptar — remezclar, transformar y construir a partir del material
Bajo los siguientes términos:
- Atribución — Usted debe dar crédito de manera adecuada, brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
- NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
